Palouse Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.8M | Sell |
4,615
-56
| -1% | -$21.8K | 1.18% | 41 |
|
2025
Q1 | $2.03M | Buy |
4,671
+601
| +15% | +$261K | 1.39% | 32 |
|
2024
Q4 | $1.5M | Buy |
+4,070
| New | +$1.5M | 1% | 44 |
|
2021
Q1 | – | Sell |
-4,538
| Closed | -$1.46M | – | 97 |
|
2020
Q4 | $1.46M | Sell |
4,538
-123
| -3% | -$39.5K | 0.77% | 53 |
|
2020
Q3 | $1.25M | Sell |
4,661
-365
| -7% | -$98K | 0.7% | 51 |
|
2020
Q2 | $1.32M | Sell |
5,026
-339
| -6% | -$89.2K | 0.7% | 49 |
|
2020
Q1 | $1.22M | Sell |
5,365
-486
| -8% | -$110K | 0.72% | 48 |
|
2019
Q4 | $1.77M | Sell |
5,851
-370
| -6% | -$112K | 0.67% | 46 |
|
2019
Q3 | $1.49M | Buy |
+6,221
| New | +$1.49M | 0.55% | 55 |
|
2017
Q3 | – | Sell |
-27,316
| Closed | -$5.14M | – | 110 |
|
2017
Q2 | $5.14M | Sell |
27,316
-1,452
| -5% | -$273K | 1.87% | 19 |
|
2017
Q1 | $4.76M | Sell |
28,768
-197
| -0.7% | -$32.6K | 1.81% | 22 |
|
2016
Q4 | $4.16M | Buy |
28,965
+13,290
| +85% | +$1.91M | 1.7% | 23 |
|
2016
Q3 | $1.96M | Buy |
+15,675
| New | +$1.96M | 0.84% | 52 |
|
2013
Q3 | – | Sell |
-47,440
| Closed | -$3.88M | – | 116 |
|
2013
Q2 | $3.88M | Buy |
+47,440
| New | +$3.88M | 1.65% | 26 |
|